Palacios Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Palacios Wealth Management's BMY Position: Q1 2026 in Review
Palacios Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2026, buying an estimated $5.6K and bringing the position to 6,167 shares worth $374K. The position accounts for 0.23% of the portfolio, ranked #55.
Palacios Wealth Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $477K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Palacios Wealth Management held 6,167 shares of Bristol-Myers Squibb worth $374K as of Q1 2026.
- Palacios Wealth Management bought 96 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.6K.
- Bristol-Myers Squibb made up 0.23% of Palacios Wealth Management's portfolio in Q1 2026, its #55 holding.
- Palacios Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- Palacios Wealth Management's Bristol-Myers Squibb position peaked at $477K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Palacios Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.